skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Management of the asymptomatic BRCA mutation carrier

Review

(1849) Views  (615) Full article downloads

Authors: Paige Teller, Rita K Kramer

Published Date November 2010 Volume 2010:3 Pages 121 - 131
DOI: http://dx.doi.org/10.2147/TACG.S8882

Paige Teller1, Rita K Kramer2
1Surgical Oncology, 2Medical Oncology, Medical University of South Carolina, Charleston, SC, USA

Abstract: Current management of an asymptomatic BRCA mutation carrier includes early initiation and intensive cancer screening in combination with risk reduction strategies. The primary objectives of these interventions are earlier detection and cancer prevention to increase quality of life and prolonged survival. Existing recommendations are often based on the consensus of experts as there are few, supportive, randomized control trials. Management strategies for unaffected patients with BRCA mutations are continually redefined and customized as more evidence-based knowledge is acquired with regard to current intervention efficacy, mutation-related histology, and new treatment modalities. This review provides an outline of current, supported management principles, and interventions in the care of the asymptomatic BRCA mutation carrier. Topics covered include surveillance modalities and risk reduction achieved through behavioral modification, chemoprevention, and prophylactic surgery.

Keywords: high risk, screening, risk reduction, hereditary breast cancer syndrome






Readers of this article also read:

Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Genetic contribution and associated pathophysiology in end-stage renal disease
Psychogenetics of post-traumatic stress disorder: a short review
Everolimus-eluting stents: update on current clinical studies
Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study
Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era
The Application of Clinical Genetics
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University